Persistence with treatment in newly treated middle-aged patients with essential hypertension

Sylvie Perreault1, Diane Lamarre, Lucie Blais

  • 1Faculty of Pharmacy, University of Montreal, Québec, Canada. sylvie.perreault@umontreal.ca

Insights

Patient persistence with antihypertensive medication declines significantly within three years, with diuretics showing the lowest adherence rates. Early intervention is crucial for improving long-term cardiovascular disease management.

Area of Science:

  • Pharmacology
  • Cardiology
  • Public Health

Background:

  • Antihypertensive agents reduce cardiovascular disease (CVD) morbidity/mortality.
  • Hypertension remains uncontrolled in many diagnosed patients, potentially due to poor treatment persistence.
  • Understanding persistence is key to improving hypertension management.

Purpose of the Study:

  • To evaluate persistence with antihypertensive medications.
  • To identify determinants of persistence among newly treated patients.

Main Methods:

  • A cohort of 21,011 newly treated essential hypertension patients (50-64 years) was analyzed.
  • Prescription data from 1998-2000 from Quebec administrative database used.
  • Kaplan-Meier and Cox regression models assessed persistence rates and discontinuation factors over 3 years.

Main Results:

  • Persistence dropped from 75% at 6 months to 55% over 3 years.
  • Non-diuretic antihypertensives or combination therapy improved persistence (HR 0.71).
  • Diabetes (HR 0.86) and dyslipidemia (HR 0.71) were associated with increased persistence.

Conclusions:

  • Persistence barriers emerge early, with adherence declining over time.
  • Diuretic therapy demonstrated the lowest patient persistence rates.
  • Strategies to enhance early adherence are vital for effective hypertension control.
Abstract

Related Concept Videos

Hypertension IV: Drug Therapy and Lifestyle Modifications01:28

Hypertension IV: Drug Therapy and Lifestyle Modifications

Multiple classes of antihypertensive medications are employed in treating hypertension. The most commonly recommended first-line treatments include:Thiazide Diuretics, such as chlorthalidone, increase sodium and water excretion from the body, reducing blood volume and blood pressure.Angiotensin-converting enzyme inhibitors, like lisinopril, block the conversion of angiotensin I to II, a potent vasoconstrictor lowering blood pressure.Angiotensin II Receptor Blockers (ARBs) prevent angiotensin II...
Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
Hypertension V: Nursing Management01:23

Hypertension V: Nursing Management

The nursing management of hypertension involves accurately assessing symptoms, making a comprehensive nursing diagnosis, collaborating with patients to set goals, and implementing targeted interventions to mitigate the condition's impact and improve patient well-being.Comprehensive AssessmentThe initial step in nursing care for hypertension involves a thorough patient assessment. It includes evaluating symptoms such as headaches, dizziness, blurred vision, and previous hypertension episodes.
Hypertension I: Introduction01:28

Hypertension I: Introduction

Hypertension is a widespread, long-term medical condition where blood pressure in the arteries remains elevated. It is characterized by systolic blood pressure readings of 130 mm Hg or above or diastolic blood pressure (DBP) readings of 80 mm Hg or higher. Unmanaged hypertension poses significant health risks, making the distinction between primary (or essential) hypertension and secondary hypertension crucial, as their management and implications vary.Primary HypertensionPrimary hypertension,...
Hypertension II: Pathophysiology01:29

Hypertension II: Pathophysiology

Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...